FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289526563> ?p ?o ?g. }

• W4289526563 endingPage "e1018" @default.
• W4289526563 startingPage "e1009" @default.
• W4289526563 abstract "Introduction/Background Leveraging the Follicular Lymphoma Analysis of Surrogacy Hypothesis database of individual patient data from first-line clinical trials, we studied the clinical course of follicular lymphoma (FL) and investigated clinical factors associated with FL outcomes. Patients and Methods We examined 2428 patients from 8 randomized trials using multistate survival models with 4 states: induction treatment, progression, death from FL, and death from other causes. We utilized Aalen-Johansen estimator and Cox models to assess the likelihood of FL outcomes and quantify predictors’ effects. Results Two-year progression, FL-related death, and death from other causes estimates were 26.5%, 3.4% and 1.4%, respectively. FL-associated deaths were the primary cause of mortality within 10 years of follow-up. Male sex (hazard ratio: 1.25; 95% confidence interval: 1.05-1.47), > 4 involved nodal areas (1.51; 1.23-1.86), elevated LDH (1.20; 1.01-1.43), low hemoglobin (1.44; 1.15-1.81), and elevated β-2 levels (1.23; 1.02-1.47) increased risk of progression. CD20-targeting agents reduced risks for progression (0.29; 0.22-0.39), death from FL (0.05; 0.01-0.20), and death from other causes without progression (0.13; 0.05-0.33) and following progression (0.52; 0.30-0.92). Estimated 2-year progression rates were 22.3% and 43.5% with or without CD20-targeting agents, respectively. Two-year FL-associated mortality rate was 8.3% among patients without CD20-targeting agents, 5.4% with B-symptoms, 4.9% with elevated LDH, and 9.1% with low hemoglobin. Conclusion This study identified independent contributions of baseline clinical factors to distinct outcomes for patients with FL following first-line therapy on a clinical trial. Similar analytical approaches are needed to increase understanding of factors that influence FL outcomes in other settings." @default.
• W4289526563 created "2022-08-03" @default.
• W4289526563 creator A5029160106 @default.
• W4289526563 creator A5032345930 @default.
• W4289526563 creator A5034043513 @default.
• W4289526563 creator A5044110524 @default.
• W4289526563 creator A5045311601 @default.
• W4289526563 creator A5049291606 @default.
• W4289526563 creator A5051605599 @default.
• W4289526563 creator A5055368165 @default.
• W4289526563 creator A5056946123 @default.
• W4289526563 creator A5065902991 @default.
• W4289526563 creator A5067184222 @default.
• W4289526563 creator A5070411980 @default.
• W4289526563 creator A5077769345 @default.
• W4289526563 creator A5082892912 @default.
• W4289526563 creator A5086354986 @default.
• W4289526563 creator A5090742905 @default.
• W4289526563 date "2022-11-01" @default.
• W4289526563 modified "2023-10-17" @default.
• W4289526563 title "Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials" @default.
• W4289526563 cites W1970648523 @default.
• W4289526563 cites W2045330558 @default.
• W4289526563 cites W2061272096 @default.
• W4289526563 cites W2061740861 @default.
• W4289526563 cites W2085346499 @default.
• W4289526563 cites W2101648653 @default.
• W4289526563 cites W2108131857 @default.
• W4289526563 cites W2113166318 @default.
• W4289526563 cites W2114233385 @default.
• W4289526563 cites W2132103750 @default.
• W4289526563 cites W2132443196 @default.
• W4289526563 cites W2135321054 @default.
• W4289526563 cites W2136326451 @default.
• W4289526563 cites W2138404218 @default.
• W4289526563 cites W2152162065 @default.
• W4289526563 cites W2154643481 @default.
• W4289526563 cites W2159982513 @default.
• W4289526563 cites W2160093471 @default.
• W4289526563 cites W2169209759 @default.
• W4289526563 cites W2169578616 @default.
• W4289526563 cites W2518731208 @default.
• W4289526563 cites W2566546873 @default.
• W4289526563 cites W2761878534 @default.
• W4289526563 cites W2766293656 @default.
• W4289526563 cites W2784962174 @default.
• W4289526563 cites W2789039113 @default.
• W4289526563 cites W2795961656 @default.
• W4289526563 cites W2902350206 @default.
• W4289526563 cites W2902708710 @default.
• W4289526563 cites W2908320246 @default.
• W4289526563 cites W2955112147 @default.
• W4289526563 cites W2956178192 @default.
• W4289526563 cites W2963759094 @default.
• W4289526563 cites W3010290514 @default.
• W4289526563 cites W3021761019 @default.
• W4289526563 cites W3072498842 @default.
• W4289526563 cites W3080346086 @default.
• W4289526563 cites W3202752956 @default.
• W4289526563 cites W3212609199 @default.
• W4289526563 cites W3213194096 @default.
• W4289526563 cites W4206293020 @default.
• W4289526563 cites W4255164806 @default.
• W4289526563 cites W4293203547 @default.
• W4289526563 doi "https://doi.org/10.1016/j.clml.2022.07.015" @default.
• W4289526563 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36045021" @default.
• W4289526563 hasPublicationYear "2022" @default.
• W4289526563 type Work @default.
• W4289526563 citedByCount "0" @default.
• W4289526563 crossrefType "journal-article" @default.
• W4289526563 hasAuthorship W4289526563A5029160106 @default.
• W4289526563 hasAuthorship W4289526563A5032345930 @default.
• W4289526563 hasAuthorship W4289526563A5034043513 @default.
• W4289526563 hasAuthorship W4289526563A5044110524 @default.
• W4289526563 hasAuthorship W4289526563A5045311601 @default.
• W4289526563 hasAuthorship W4289526563A5049291606 @default.
• W4289526563 hasAuthorship W4289526563A5051605599 @default.
• W4289526563 hasAuthorship W4289526563A5055368165 @default.
• W4289526563 hasAuthorship W4289526563A5056946123 @default.
• W4289526563 hasAuthorship W4289526563A5065902991 @default.
• W4289526563 hasAuthorship W4289526563A5067184222 @default.
• W4289526563 hasAuthorship W4289526563A5070411980 @default.
• W4289526563 hasAuthorship W4289526563A5077769345 @default.
• W4289526563 hasAuthorship W4289526563A5082892912 @default.
• W4289526563 hasAuthorship W4289526563A5086354986 @default.
• W4289526563 hasAuthorship W4289526563A5090742905 @default.
• W4289526563 hasConcept C126322002 @default.
• W4289526563 hasConcept C143998085 @default.
• W4289526563 hasConcept C168563851 @default.
• W4289526563 hasConcept C207103383 @default.
• W4289526563 hasConcept C2777058707 @default.
• W4289526563 hasConcept C2779338263 @default.
• W4289526563 hasConcept C44249647 @default.
• W4289526563 hasConcept C535046627 @default.
• W4289526563 hasConcept C71924100 @default.
• W4289526563 hasConceptScore W4289526563C126322002 @default.
• W4289526563 hasConceptScore W4289526563C143998085 @default.
• W4289526563 hasConceptScore W4289526563C168563851 @default.

• next